Literature DB >> 25912138

Differential regulation of HIF-1α and HIF-2α in neuroblastoma: Estrogen-related receptor alpha (ERRα) regulates HIF2A transcription and correlates to poor outcome.

Arash Hamidian1, Kristoffer von Stedingk1, Matilda Munksgaard Thorén1, Sofie Mohlin1, Sven Påhlman2.   

Abstract

Hypoxia-inducible factors (HIFs) are differentially regulated in tumor cells. While the current paradigm supports post-translational regulation of the HIF-α subunits, we recently showed that hypoxic HIF-2α is also transcriptionally regulated via insulin-like growth factor (IGF)-II in the childhood tumor neuroblastoma. Here, we demonstrate that transcriptional regulation of HIF-2α seems to be restricted to neural cell-derived tumors, while HIF-1α is canonically regulated at the post-translational level uniformly across different tumor forms. Enhanced expression of HIF2A mRNA at hypoxia is due to de novo transcription rather than increased mRNA stability, and chemical stabilization of the HIF-α proteins at oxygen-rich conditions unexpectedly leads to increased HIF2A transcription. The enhanced HIF2A levels do not seem to be dependent on active HIF-1. Using a transcriptome array approach, we identified members of the Peroxisome proliferator-activated receptor gamma coactivator (PGC)/Estrogen-related receptor (ERR) complex families as potential regulators of HIF2A. Knockdown or inhibition of one of the members, ERRα, leads to decreased expression of HIF2A, and high expression of the ERRα gene ESRRA correlates with poor overall and progression-free survival in a clinical neuroblastoma material consisting of 88 tumors. Thus, targeting of ERRα and pathways regulating transcriptional HIF-2α are promising therapeutic avenues in neuroblastoma.
Copyright © 2015 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  ERRα; HIF-2α; Hypoxia; Neuroblastoma; Transcription

Mesh:

Substances:

Year:  2015        PMID: 25912138     DOI: 10.1016/j.bbrc.2015.04.083

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  11 in total

1.  Differential but Complementary HIF1α and HIF2α Transcriptional Regulation.

Authors:  Nicholas L Downes; Nihay Laham-Karam; Minna U Kaikkonen; Seppo Ylä-Herttuala
Journal:  Mol Ther       Date:  2018-05-09       Impact factor: 11.454

2.  Prolyl Hydroxylase Domain Protein Inhibitor Not Harboring a 2-Oxoglutarate Scaffold Protects against Hypoxic Stress.

Authors:  Kento Sonoda; Sudarma Bogahawatta; Akito Katayama; Saki Ujike; Sae Kuroki; Naho Kitagawa; Kohichi Hirotsuru; Norio Suzuki; Toshio Miyata; Shin-Ichi Kawaguchi; Tadayuki Tsujita
Journal:  ACS Pharmacol Transl Sci       Date:  2022-04-13

Review 3.  PD-L1, inflammation, non-coding RNAs, and neuroblastoma: Immuno-oncology perspective.

Authors:  Palanisamy Nallasamy; Srinivas Chava; Sumit S Verma; Shruti Mishra; Santhi Gorantla; Don W Coulter; Siddappa N Byrareddy; Surinder K Batra; Subash C Gupta; Kishore B Challagundla
Journal:  Semin Cancer Biol       Date:  2017-11-28       Impact factor: 15.707

4.  Thiamine deficiency activates hypoxia inducible factor-1α to facilitate pro-apoptotic responses in mouse primary astrocytes.

Authors:  Kristy Zera; Jason Zastre
Journal:  PLoS One       Date:  2017-10-18       Impact factor: 3.240

5.  Vascular niche IL-6 induces alternative macrophage activation in glioblastoma through HIF-2α.

Authors:  Qirui Wang; Zhenqiang He; Menggui Huang; Tianrun Liu; Yanling Wang; Haineng Xu; Hao Duan; Peihong Ma; Lin Zhang; Scott S Zamvil; Juan Hidalgo; Zhenfeng Zhang; Donald M O'Rourke; Nadia Dahmane; Steven Brem; Yonggao Mou; Yanqing Gong; Yi Fan
Journal:  Nat Commun       Date:  2018-02-08       Impact factor: 14.919

6.  A HIF-independent, CD133-mediated mechanism of cisplatin resistance in glioblastoma cells.

Authors:  Eroje M Ahmed; Gagori Bandopadhyay; Beth Coyle; Anna Grabowska
Journal:  Cell Oncol (Dordr)       Date:  2018-02-28       Impact factor: 6.730

7.  AQP1 Is Up-Regulated by Hypoxia and Leads to Increased Cell Water Permeability, Motility, and Migration in Neuroblastoma.

Authors:  Zihe Huo; Mihai Lomora; Urs Kym; Cornelia Palivan; Stefan G Holland-Cunz; Stephanie J Gros
Journal:  Front Cell Dev Biol       Date:  2021-02-11

8.  Proteotranscriptomic Analysis Reveals Stage Specific Changes in the Molecular Landscape of Clear-Cell Renal Cell Carcinoma.

Authors:  Benjamin A Neely; Christopher E Wilkins; Laura A Marlow; Dariya Malyarenko; Yunee Kim; Alexandr Ignatchenko; Heather Sasinowska; Maciek Sasinowski; Julius O Nyalwidhe; Thomas Kislinger; John A Copland; Richard R Drake
Journal:  PLoS One       Date:  2016-04-29       Impact factor: 3.240

9.  Selective tubular activation of hypoxia-inducible factor-2α has dual effects on renal fibrosis.

Authors:  Kyoung Hye Kong; Hyung Jung Oh; Beom Jin Lim; Minsuk Kim; Ki-Hwan Han; Youn-Hee Choi; Kihwan Kwon; Bo Young Nam; Kyoung Sook Park; Jung Tak Park; Seung Hyeok Han; Tae-Hyun Yoo; Shina Lee; Seung-Jung Kim; Duk-Hee Kang; Kyu Bok Choi; Vera Eremina; Susan E Quaggin; Dong-Ryeol Ryu; Shin-Wook Kang
Journal:  Sci Rep       Date:  2017-09-12       Impact factor: 4.379

10.  A HIF-LIMD1 negative feedback mechanism mitigates the pro-tumorigenic effects of hypoxia.

Authors:  Daniel E Foxler; Katherine S Bridge; John G Foster; Paul Grevitt; Sean Curry; Kunal M Shah; Kathryn M Davidson; Ai Nagano; Emanuela Gadaleta; Hefin I Rhys; Paul T Kennedy; Miguel A Hermida; Ting-Yu Chang; Peter E Shaw; Louise E Reynolds; Tristan R McKay; Hsei-Wei Wang; Paulo S Ribeiro; Michael J Plevin; Dimitris Lagos; Nicholas R Lemoine; Prabhakar Rajan; Trevor A Graham; Claude Chelala; Kairbaan M Hodivala-Dilke; Ian Spendlove; Tyson V Sharp
Journal:  EMBO Mol Med       Date:  2018-08       Impact factor: 14.260

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.